Cargando…

A systematic review and meta-analysis of randomized controlled trials, juxtaposing the control of glycemia and blood pressure between large dose empagliflozin and placebo among type 1 diabetes patients

OBJECTIVES: While empagliflozin (25 mg) is used to treat type-2 diabetes mellitus patients with optimum renal functioning, its efficacy and safety in type-1 diabetes mellitus (T1DM) is not yet established. Therefore, this study aimed to compare insulin-treated T1DM patients’ (with adequate renal fun...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saha, Sumanta, Saha, Sujata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Qassim Uninversity 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069660/ https://www.ncbi.nlm.nih.gov/pubmed/32206059

Ejemplares similares

A comparison of the risk of cesarean section in gestational diabetes mellitus patients supplemented antenatally with vitamin D containing supplements versus placebo: A systematic review and meta-analysis of double-blinded randomized controlled trials
por: Saha, Sumanta, et al.
Publicado: (2020)

Changes in anthropometric and blood 25-hydroxyvitamin D measurements in antenatal vitamin supplemented gestational diabetes mellitus patients: a systematic review and meta-analysis of randomized controlled trials
por: Saha, Sumanta, et al.
Publicado: (2021)

The effects of prenatal dietary supplements on blood glucose and lipid metabolism in gestational diabetes mellitus patients: A systematic review and network meta-analysis protocol of randomized controlled trials
por: Saha, Sumanta, et al.
Publicado: (2022)

Shoulder joint mobility in patients with primary adhesive capsulitis after treatment with continuous mode of ultrasound: A systematic review of randomized controlled trials
por: Saha, Sumanta, et al.
Publicado: (2019)

Participant attrition and perinatal outcomes in prenatal vitamin D-supplemented gestational diabetes mellitus patients in Asia: A meta-analysis
por: Saha, Sumanta, et al.
Publicado: (2022)

Acute and Chronic Effects of SGLT2 Inhibitor Empagliflozin on Renal Oxygenation and Blood Pressure Control in Nondiabetic Normotensive Subjects: A Randomized, Placebo‐Controlled Trial
por: Zanchi, Anne, et al.
Publicado: (2020)

Endodontic Management of Teeth Juxtaposed to Haemangioma
por: Mani, Rekha Chandra, et al.
Publicado: (2017)

Diabetes prevalence and mortality in COVID-19 patients: a systematic review, meta‐analysis, and meta‐regression
por: Saha, Sumanta, et al.
Publicado: (2021)

Comparative effectiveness of adjunct non-pharmacological interventions on maternal and neonatal outcomes in gestational diabetes mellitus patients: A systematic review and network meta-analysis protocol of randomized controlled trials
por: Saha, Sumanta
Publicado: (2022)

The risk of morbidities in newborns of antenatal vitamin D supplemented gestational diabetes mellitus patients
por: Saha, Sumanta, et al.
Publicado: (2020)

The impact of the undetected COVID-19 cases on its transmission dynamics
por: Saha, Sujata, et al.
Publicado: (2021)

Epidemiological burden of parents being the index cases of COVID-19 infected children
por: Saha, Sumanta, et al.
Publicado: (2021)

Cardiovascular safety of empagliflozin in patients with type 2 diabetes: a meta‐analysis of data from randomized placebo‐controlled trials
por: Salsali, A., et al.
Publicado: (2016)

Rabies elimination research: juxtaposing optimism, pragmatism and realism
por: Cleaveland, Sarah, et al.
Publicado: (2017)

Juxtaposed atrial appendages: A curiosity with some clinical relevance
por: Singhi, Anil Kumar, et al.
Publicado: (2016)

Fungi as Endophytes in Artemisia thuscula: Juxtaposed Elements of Diversity and Phylogeny
por: Cosoveanu, Andreea, et al.
Publicado: (2018)

Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME™)
por: Zinman, Bernard, et al.
Publicado: (2014)

Juxtapose: a gene-embedding approach for comparing co-expression networks
por: Ovens, Katie, et al.
Publicado: (2021)

Juxtaposing Medical Centers Using Different Questionnaires Through Score Predictors
por: Puga, Clara, et al.
Publicado: (2022)

Juxtaposing Sub-Sahara Africa’s energy poverty and renewable energy potential
por: Mukhtar, Mustapha, et al.
Publicado: (2023)

Dopaminergic Control of Inflammation and Glycemia in Sepsis and Diabetes
por: Feketeova, Eleonora, et al.
Publicado: (2018)

Potassium Intake and Blood Pressure: A Dose‐Response Meta‐Analysis of Randomized Controlled Trials
por: Filippini, Tommaso, et al.
Publicado: (2020)

Control of glycemia and blood pressure in British adults with diabetes mellitus and subsequent therapy choices: a comparison across health states
por: McAlister, Finlay A., et al.
Publicado: (2018)

Efficacy and safety of empagliflozin for type 2 diabetes mellitus: Meta-analysis of randomized controlled trials
por: Zhang, Yun-Jing, et al.
Publicado: (2018)

Empagliflozin in Patients With Heart Failure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Pan, Deng, et al.
Publicado: (2021)

Empagliflozin as adjunct to insulin in patients with type 1 diabetes: a 4‐week, randomized, placebo‐controlled trial (EASE‐1)
por: Pieber, T. R., et al.
Publicado: (2015)

Effect of conjugated linoleic acid on blood pressure: a meta-analysis of randomized, double-blind placebo-controlled trials
por: Yang, Jing, et al.
Publicado: (2015)

Reaching an ACCORD on Glycemia and Systolic Blood Pressure Targets in Type 2 Diabetes Mellitus
por: MacDonald, Thomas M., et al.
Publicado: (2018)

Blinded Withdrawal of Long-Term Randomized Treatment With Empagliflozin or Placebo in Patients With Heart Failure
por: Packer, Milton, et al.
Publicado: (2023)

Sister DNA Entrapment between Juxtaposed Smc Heads and Kleisin of the Cohesin Complex
por: Chapard, Christophe, et al.
Publicado: (2019)

Secondary analyses to assess the profound effects of empagliflozin on endothelial function in patients with type 2 diabetes and established cardiovascular diseases: The placebo‐controlled double‐blind randomized effect of empagliflozin on endothelial function in cardiovascular high risk diabetes mellitus: Multi‐center placebo‐controlled double‐blind randomized trial
por: Tanaka, Atsushi, et al.
Publicado: (2020)

Metformin Improves Endothelial Function and Reduces Blood Pressure in Diabetic Spontaneously Hypertensive Rats Independent from Glycemia Control: Comparison to Vildagliptin
por: Hamidi Shishavan, Mahdi, et al.
Publicado: (2017)

Rationale and design of a multicenter placebo-controlled double-blind randomized trial to evaluate the effect of empagliflozin on endothelial function: the EMBLEM trial
por: Tanaka, Atsushi, et al.
Publicado: (2017)

Efficacy and safety of empagliflozin as add‐on to insulin in Japanese patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled trial
por: Sone, Hirohito, et al.
Publicado: (2019)

Effects of empagliflozin on markers of calcium and phosphate homeostasis in patients with type 2 diabetes – Data from a randomized, placebo-controlled study
por: Rau, Matthias, et al.
Publicado: (2022)

Effect of empagliflozin on coronary microvascular function in patients with type 2 diabetes mellitus–A randomized, placebo-controlled cross-over study
por: Suhrs, Hannah Elena, et al.
Publicado: (2022)

Empagliflozin for the treatment of non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials
por: Tang, Xue, et al.
Publicado: (2022)

Compliance and barriers to self-monitoring of blood glucose in patients with gestational diabetes mellitus: A systematic review
por: Saha, Sumanta
Publicado: (2019)

Empagliflozin as add‐on to linagliptin in a fixed‐dose combination in Japanese patients with type 2 diabetes: Glycaemic efficacy and safety profile in a 52‐week, randomized, placebo‐controlled trial
por: Kawamori, Ryuzo, et al.
Publicado: (2018)

Linagliptin as add‐on to empagliflozin in a fixed‐dose combination in Japanese patients with type 2 diabetes: Glycaemic efficacy and safety profile in a two‐part, randomized, placebo‐controlled trial
por: Kaku, Kohei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vh214j121ej8etc6755gj38t2r